Categories
Connect with us on LinkedIn
Why a Life Sciences Museum Matters—And What It Can Teach Us About the Future of Medicine
What a Museum of Medicine can teach us about trials, trust, and how the public sees (or doesn’t...
Castor Steps Up to Preserve Critical Research Amid NIH Funding Cuts
Castor has announced free access to its clinical trial technology platform for U.S. researchers impacted by recent NIH...
Participant View eCOA | ePRO
Reduce participant and site burden with a simple 2 step onboarding and user-friendly app. Secure questionnaires via email...
eCOA/ePRO factsheet
Download our ePRO/eCOA factsheet to view an overview of our services.
Strategies to Minimize Participant and Healthcare Provider Burden in Clinical Trials
This article examines strategies to reduce participant and provider burden in clinical trials while ensuring high-quality data collection....
2024: Castor Year in Review
As we close the year, the Castor team shares vital milestones the company has achieved to make patient-centric...
eCOA Evolution: Have We Overcomplicated What Used to Work?
A blueprint for engineering elegant eCOA solutions that make complex trials feel simple.
Unlocking FDA’s Vision for PRO Collection in RWE: Timing, Methods, and Insights
Discover FDA's guidance on collecting PROs for Real-World Evidence (RWE), focusing on timing, methods, and improving data quality.
FDA’s Vision on PRO/eCOA Collection for RWE: Timing and Methods Explained
Watch back as our panel of experts discuss how the FDA views the collection of patient-reported outcomes for...
Castor Product Spotlight: What’s new in 2024?
In this on-demand webinar, we delve into the latest product updates on eCOA, data entry, reports, and dashboards....
eCOA: Afterthought or Essential Strategy? An Expert’s View on Choosing and Developing an eCOA Strategy
The Evolving Landscape of eCOA in Clinical Trials Clinical trials have long grappled with the complexities of data...
Evaluating “Bother” as a Component of Patient-Reported Outcomes in Clinical Studies
Patient-reported outcome (PRO) instruments refer to multiple scales and questionnaires designed to collect patients’ personal feedback on their...
New Industry Standard Research Report Sheds Light on eCOA/ePRO Market Dynamics
The latest report from Industry Standard Research (ISR) Sheds Light on eCOA/ePRO Market Dynamics. The Performance of Castor...
Under Pressure: How Aktiia Brought Their Continuous BP Device to Global Markets with high quality data
Watch this on-demand LinkedIn Live webinar with Castor CEO & founder, Derk Arts, featuring fellow data-driven pioneer, Jay...
Can BYOD help us end an era of waste and burden in eCOA?
Bring Your Own Device (BYOD) represents the future of eCOA, and prioritizes flexibility & convenience for trial participants....
Measuring the true patient experience in Cancer Trials with eCOA / ePRO
Shedding light on the complexities and advancements in measuring PROs, drug tolerability, and quality of life in cancer...
The Place of COAs / PROs in the Future of Healthcare
Learn how integrating Patient-Reported Outcomes (PROs) into clinical trials can drive success in Value-Based Care (VBC).
How to Incorporate Remote Technology in Your Next Medical Device Trial
Researchers are looking to incorporate remote technologies into medical device trials for a wide range of device classifications....
Connect with us on LinkedIn
